Advertisement
ALC or COO or DHR
Which Stock Would AI Choose? Alcon Inc. (ALC) vs. The Cooper Companies, Inc. (COO) vs. Danaher Corporation (DHR) Stock Comparison
Key Takeaways
- Alcon Inc. (ALC), The Cooper Companies, Inc. (COO), and Danaher Corporation (DHR) operate primarily in the healthcare sector with exposure to medical devices and life sciences, though DHR maintains broader diversification across diagnostics and biotechnology.
- Recent market activity shows varying price responses, with DHR demonstrating notable volatility tied to earnings and acquisition developments, while ALC and COO have exhibited more contained movements within the eye care and surgical segments.
- Business models differ in focus: ALC and COO emphasize vision care and related surgical products, whereas DHR leverages the Danaher Business System for operational efficiency across multiple platforms.
- Sector exposure positions all three within healthcare, with sensitivity to regulatory approvals, reimbursement trends, and innovation pipelines influencing relative performance.
- Market sentiment reflects ongoing evaluation of growth catalysts, including product launches for ALC and COO versus M&A (mergers and acquisitions) activity and earnings guidance for DHR.
- Valuation sensitivity and stability metrics highlight trade-offs between specialized eye care plays and DHR’s larger-scale, multi-segment approach.
Introduction
This comparison examines Alcon Inc. (ALC), The Cooper Companies, Inc. (COO), and Danaher Corporation (DHR) to provide traders and investors with an objective view of their relative positioning in the current market environment. These stocks attract attention from those focused on healthcare equities, particularly in medical devices and life sciences. The analysis highlights differences in business models, recent performance trends, and key drivers that may influence portfolio allocation decisions for investors seeking exposure to established healthcare names with varying degrees of specialization and diversification.
ALC Overview and Recent Performance
Alcon Inc. (ALC) is a global leader in eye care, offering products across vision care and surgical segments, including contact lenses, intraocular lenses, and surgical equipment. In recent weeks, the stock has reflected steady interest amid broader healthcare sector dynamics, with performance influenced by ongoing product innovation and demand in ophthalmology markets. Sentiment has been shaped by consistent operational execution and exposure to elective procedures, contributing to relatively stable price behavior compared to more volatile peers during recent market activity.
COO Overview and Recent Performance
The Cooper Companies, Inc. (COO) operates through CooperVision, focused on contact lenses, and CooperSurgical, addressing women’s health and fertility products. Recent market activity has shown measured responses in the stock price, supported by steady demand in core vision care categories and incremental contributions from the surgical segment. Key developments, including portfolio expansions and market positioning in specialty lenses, have helped maintain balanced sentiment amid sector-wide considerations around consumer healthcare spending.
DHR Overview and Recent Performance
Danaher Corporation (DHR) applies its Danaher Business System across life sciences, diagnostics, and biotechnology platforms, with significant revenue from instruments, consumables, and services. In recent weeks, the stock has experienced fluctuations linked to first-quarter earnings results and acquisition-related news, including the Masimo transaction approval. Broader market activity reflects investor focus on revenue growth trajectories and margin performance, resulting in more pronounced price movements relative to specialized peers.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available that trade thousands of different tickers. Only those demonstrating strong suitability for prevailing market conditions earn placement in this section. Available bots span a wide range of trading styles, strategies, timeframes, and performance statistics, with many showing win rates and return profiles tailored to specific assets. Users can explore diverse options to align with individual risk preferences and market outlooks. Visit the Trending AI Robots page for detailed bot profiles and performance data.
Head-to-Head Comparison
Alcon Inc. (ALC) and The Cooper Companies, Inc. (COO) share concentrated exposure to vision care and surgical ophthalmology, creating similar sensitivities to procedure volumes and innovation cycles, while Danaher Corporation (DHR) offers diversified revenue streams that may buffer sector-specific risks but introduce complexity from multiple end markets. Recent momentum has favored steadier trajectories for the eye care specialists amid contained volatility, contrasting with DHR’s sharper reactions to earnings and M&A (mergers and acquisitions) updates. Valuation considerations highlight potential trade-offs between growth multiples in specialized segments and DHR’s scale-driven efficiency metrics. Market sentiment remains tied to macroeconomic factors affecting healthcare spending, with each stock presenting distinct risk profiles based on geographic exposure and product concentration.
Tickeron AI Verdict
Based on observable factors including trend consistency and relative stability in recent market activity, Tickeron’s AI models indicate a probabilistic preference toward Alcon Inc. (ALC) at present, citing more contained volatility and alignment with steady demand patterns in its core segments. The Cooper Companies, Inc. (COO) shows comparable positioning with balanced metrics, while Danaher Corporation (DHR) reflects greater sensitivity to catalysts that could support or challenge performance depending on execution. This assessment draws from historical patterns and current positioning without implying future outcomes.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 1 FA rating(s) are green whileCOO’s FA Score has 0 green FA rating(s), and DHR’s FA Score reflects 1 green FA rating(s).
- ALC’s FA Score: 1 green, 4 red.
- COO’s FA Score: 0 green, 5 red.
- DHR’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 5 TA indicator(s) are bullish while COO’s TA Score has 5 bullish TA indicator(s), and DHR’s TA Score reflects 5 bullish TA indicator(s).
- ALC’s TA Score: 5 bullish, 3 bearish.
- COO’s TA Score: 5 bullish, 4 bearish.
- DHR’s TA Score: 5 bullish, 4 bearish.
Price Growth
ALC (@Pharmaceuticals: Other) experienced а +0.78% price change this week, while COO (@Pharmaceuticals: Other) price change was +10.01% , and DHR (@Medical Specialties) price fluctuated +0.89% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.97%. For the same industry, the average monthly price growth was -0.88%, and the average quarterly price growth was -13.78%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.28%. For the same industry, the average monthly price growth was +13.41%, and the average quarterly price growth was -7.34%.
Reported Earning Dates
ALC is expected to report earnings on Aug 10, 2026.
COO is expected to report earnings on Sep 02, 2026.
DHR is expected to report earnings on Jul 28, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.97% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical Specialties (-3.28% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| ALC | COO | DHR | |
| Capitalization | 32.8B | 13.1B | 130B |
| EBITDA | 2.54B | 1.08B | 7.08B |
| Gain YTD | -15.226 | -17.838 | -19.320 |
| P/E Ratio | 40.01 | 33.50 | 35.72 |
| Revenue | 10.6B | 4.15B | 24.8B |
| Total Cash | 1.66B | 125M | 5.7B |
| Total Debt | 5.25B | 2.5B | 18.5B |
ALC | COO | DHR | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 57 | 29 | 28 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 18 Undervalued | 76 Overvalued | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 86 | 81 | |
PRICE GROWTH RATING 1..100 | 62 | 57 | 58 | |
P/E GROWTH RATING 1..100 | 48 | 54 | 55 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 21 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DHR's Valuation (8) in the Medical Specialties industry is in the same range as ALC (18) in the Hospital Or Nursing Management industry, and is significantly better than the same rating for COO (76) in the Medical Specialties industry. This means that DHR's stock grew similarly to ALC’s and significantly faster than COO’s over the last 12 months.
DHR's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ALC (100) in the Hospital Or Nursing Management industry, and is in the same range as COO (100) in the Medical Specialties industry. This means that DHR's stock grew similarly to ALC’s and similarly to COO’s over the last 12 months.
DHR's SMR Rating (81) in the Medical Specialties industry is in the same range as COO (86) in the Medical Specialties industry, and is in the same range as ALC (89) in the Hospital Or Nursing Management industry. This means that DHR's stock grew similarly to COO’s and similarly to ALC’s over the last 12 months.
COO's Price Growth Rating (57) in the Medical Specialties industry is in the same range as DHR (58) in the Medical Specialties industry, and is in the same range as ALC (62) in the Hospital Or Nursing Management industry. This means that COO's stock grew similarly to DHR’s and similarly to ALC’s over the last 12 months.
ALC's P/E Growth Rating (48) in the Hospital Or Nursing Management industry is in the same range as COO (54) in the Medical Specialties industry, and is in the same range as DHR (55) in the Medical Specialties industry. This means that ALC's stock grew similarly to COO’s and similarly to DHR’s over the last 12 months.
| ALC | COO | DHR | |
|---|---|---|---|
| RSI ODDS (%) | 3 days ago 51% | 3 days ago 52% | 3 days ago 75% |
| Stochastic ODDS (%) | 3 days ago 65% | 3 days ago 56% | 3 days ago 63% |
| Momentum ODDS (%) | 3 days ago 48% | 3 days ago 59% | 3 days ago 58% |
| MACD ODDS (%) | 3 days ago 55% | 3 days ago 55% | 3 days ago 64% |
| TrendWeek ODDS (%) | 3 days ago 59% | 3 days ago 55% | 3 days ago 56% |
| TrendMonth ODDS (%) | 3 days ago 50% | 3 days ago 49% | 3 days ago 54% |
| Advances ODDS (%) | 3 days ago 57% | 3 days ago 57% | 4 days ago 54% |
| Declines ODDS (%) | 5 days ago 56% | 6 days ago 60% | 6 days ago 61% |
| BollingerBands ODDS (%) | 3 days ago 58% | 3 days ago 68% | 3 days ago 53% |
| Aroon ODDS (%) | 3 days ago 57% | 3 days ago 72% | 3 days ago 60% |
Advertisement
ALC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.